Literature DB >> 12946587

Microglial activation and tyrosine hydroxylase immunoreactivity in the substantia nigral region following transient focal ischemia in rats.

Youngbuhm Huh1, Ji Wook Jung, Chan Park, Jae Ryun Ryu, Chan Young Shin, Won-Ki Kim, Jong Hoon Ryu.   

Abstract

The temporal profiles of the changes of dopaminergic cells and microglial activation induced by transient cerebral ischemia were investigated in the substantia nigra pars compacta (SNc) located outside ischemic areas of rat brain. Transient cerebral ischemia was induced by intraluminal occlusion of the right middle cerebral artery for 2 h and reperfusion was continued for 1, 2, 3, 4, 7, 10, 14, 28, 60, and 120 days. Dopaminergic cells immunostained with tyrosine hydroxylase (TH)-antibody in the ipsilateral SNc were significantly decreased at 7 days post-ischemia compared with those in the contralateral side (P<0.05). However, at 60 and 120 days, there were no significant differences between ipsilateral and contralateral side of the SNc. Unlike the TH immunoreactivity, activated microglial cells immunostained with OX-42 antibody were significantly increased at 2 and 3 days and then decreased gradually until 10 days post-ischemia. Activated microglial cells were increased at 2 weeks post-ischemia, and this pattern remained until 60 days. These results suggest that the transient changes of TH-immunoreactive cells in the SNc caused by transient focal ischemia are correlated with a biphasic microglial cell activation response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946587     DOI: 10.1016/s0304-3940(03)00743-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  The expression and release of Hsp60 in 6-OHDA induced in vivo and in vitro models of Parkinson's disease.

Authors:  Mei jiang Feng; Ling Zhang; Zhengxia Liu; Ping Zhou; Xiang Lu
Journal:  Neurochem Res       Date:  2013-08-14       Impact factor: 3.996

Review 2.  Executive (dys)function after stroke: special considerations for behavioral pharmacology.

Authors:  Jessica M Povroznik; Jenny E Ozga; Cole Vonder Haar; Elizabeth B Engler-Chiurazzi
Journal:  Behav Pharmacol       Date:  2018-10       Impact factor: 2.293

3.  Long-term changes in the ipsilateral substantia nigra after transient focal cerebral ischaemia in rats.

Authors:  Hiroto Uchida; Hironori Yokoyama; Hiroki Kimoto; Hiroyuki Kato; Tsutomu Araki
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

4.  Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity.

Authors:  Shannon Levesque; Belinda Wilson; Vincent Gregoria; Laura B Thorpe; Shannon Dallas; Vadim S Polikov; Jau-Shyong Hong; Michelle L Block
Journal:  Brain       Date:  2010-01-31       Impact factor: 13.501

5.  Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?

Authors:  Juraj Culman; Toni Jacob; Sven O Schuster; Kjell Brolund-Spaether; Leonie Brolund; Ingolf Cascorbi; Yi Zhao; Peter Gohlke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-02       Impact factor: 3.000

6.  Microglial activation and chronic neurodegeneration.

Authors:  Melinda E Lull; Michelle L Block
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 7.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

8.  Disruption of the serotonergic system after neonatal hypoxia-ischemia in a rodent model.

Authors:  Kathryn M Buller; Julie A Wixey; Hanna E Reinebrant
Journal:  Neurol Res Int       Date:  2012-02-08

Review 9.  Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective.

Authors:  Silke Neumann; Nicholas J Shields; Thomas Balle; Mary Chebib; Andrew N Clarkson
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

10.  The role of the immunoproteasome in interferon-γ-mediated microglial activation.

Authors:  Kasey E Moritz; Nikki M McCormack; Mahlet B Abera; Coralie Viollet; Young J Yauger; Gauthaman Sukumar; Clifton L Dalgard; Barrington G Burnett
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.